Literature DB >> 15114262

Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.

Tibor Tot1.   

Abstract

BACKGROUND: Immunohistochemistry plays an important role in tracing the primary site in metastatic tumors of unknown origin. Therefore, determining the cytokeratin (CK) 20/CK7 pattern of metastases is one of the most helpful procedures as the CK20+/CK7- pattern is typical of colorectal adenocarcinomas. Expression of CDX2 protein is a new, highly specific and sensitive marker of the intestinal origin of adenocarcinomas. In the present study we compared the sensitivity and specificity of CDX2 expression and the CK20+/CK7- phenotype in predicting the colorectal origin of liver metastases. MATERIAL/
METHODS: The study was carried out on a consecutive series of 125 core-needle biopsies of metastatic adenocarcinomas of the liver. Most of the patients were followed up to death, and primary tumor localization could be established in 102 cases by a combination of clinical, radiological, histological and, in some cases, autopsy data. All the needle biopsies were immunohistochemically stained for CK7, CK20 and CDX2. CDX2 expression (at 10% and 50% cut-off levels) and the CK20/CK7 pattern of the metastases were correlated to the primary site established.
RESULTS: The CK20+/CK7- pattern showed a specificity of 98.7% in predicting colorectal primary localization, which was superior to that of CDX2 expression at both cut-off levels (90% and 95.3% respectively). The sensitivity of CDX2 expression in these circumstances was 84% at the 10% cut-off, somewhat higher than that of the CK20+/CK7- phenotype (79.5%), but lower at the 50% cut-off level (72.7%).
CONCLUSIONS: The CK20+/CK7- immunophenotype is more specific in predicting the colorectal origin of liver metastasis than CDX2 expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15114262

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  4 in total

1.  CDX2 as a marker for intestinal differentiation: Its utility and limitations.

Authors:  Reda S Saad; Zeina Ghorab; Mahmoud A Khalifa; Mei Xu
Journal:  World J Gastrointest Surg       Date:  2011-11-27

2.  Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.

Authors:  Nobuyuki Ohike; Grace E Kim; Takuma Tajiri; Alyssa Krasinskas; Olca Basturk; Ipek Coban; Sudeshna Bandyopadhyay; Toshio Morohoshi; Michael Goodman; David A Kooby; Juan M Sarmiento; N Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2010-12       Impact factor: 6.394

3.  The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.

Authors:  Reyhan Bayrak; Hacer Haltas; Sibel Yenidunya
Journal:  Diagn Pathol       Date:  2012-01-23       Impact factor: 2.644

4.  Dual Stain With SATB2 and CK20/Villin Is Useful to Distinguish Colorectal Carcinomas From Other Tumors.

Authors:  Zaibo Li; Jonathan B Rock; Rachel Roth; Amy Lehman; William L Marsh; Adrian Suarez; Wendy L Frankel
Journal:  Am J Clin Pathol       Date:  2018-02-17       Impact factor: 2.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.